Exciting skincare to protect against blue light emitted by phones and devices

10 Sep 2018

Novel, dual-acting product revitalizes and protects skin against blue light and environmental aggressors around the clock.

Allergan has launched the new SkinMedica LUMIVIVE System, an innovative skincare product designed with two distinct formulas - one to shield skin from blue light and environmental aggressors during the day and another to recharge the skin's essential repair process at night.

Exciting skincare to protect against blue light emitted by phones and devices

During the day, LUMIVIVE offers full atmospheric protection and fights the signs of ageing for optimal skin health and vitality. At night, LUMIVIVE supports the skin's ability to repair itself overnight, restoring the appearance of a glowing, youthful complexion. Unlike any other product on the market, the innovative LUMIVIVETM System formulas work around the clock to support optimal skin vitality and radiance, and doesn't fade throughout the day or wash off, providing 24-hour protection and revitalization.

"Skin today is under attack from multiple invisible threats," said San Diego-based dermatologist Dr Sabrina Fabi. "Visible light, including blue light like that emitted by phones and devices, is particularly insidious, because it penetrates deeper than some forms of ultraviolet light, down into the third layer of the skin, accelerating the visible signs of ageing, such as dark spots, wrinkles, and saggy or loose skin. I am excited to help launch this innovative product that not only repairs skin and promotes a healthy-looking complexion, but is potent enough to protect us from the many environmental elements that can leave skin looking less than its best."

In clinical studies, completed in some of the most polluted cities in the world, LUMIVIVE improved the appearance of skin tone, evenness and restored stressed skin for a more luminous complexion. 85% of patients agreed that LUMIVIVE reduced the effects of environmental damage on their skin and kept their skin looking radiant throughout the day.

"People around the world, spend an average of 2 hours per day on social media, while the average American looks at their phone 47 times a day and spends about 10 hours a day in front of a screen," says Carrie Strom, Senior Vice President, US Medical Aesthetics at Allergan. "We know that blue light and pollution are all around us and can't be avoided. We felt it was important to address an unmet need by creating a system that not only protects the skin from environmental damage during the day, but also enhances the skin's ability to restore and repair skin during the sleep-repair cycle as well."

Read More

Related news

Brexit - the EU FMD's painful problem

Brexit - the EU FMD's painful problem

7 Feb 2019

Teething problems are no stranger to the implementation of new regulations, but with the EU FMD, Brexit came like a set of wisdom teeth – late, painful and problematic.

Read more 
Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

Pharmapack report predicts diversification of innovation leading to a rise in licensing and partnering

27 Jan 2019

New report highlights Germany, France and Switzerland as tier-one nations for ‘drug delivery innovation’, and warns the challenge will be to scale-up and approve promising prototypes.

Read more 
New API screening program strengthens Particle Sciences' nanomilling offering

New API screening program strengthens Particle Sciences' nanomilling offering

22 Jan 2019

Advanced formulation techniques such as nanomilling may provide an excellent route to improved bioavailability and enhanced therapeutic effect.

Read more 
Univercells introduces breakthrough vaccine manufacturing platform

Univercells introduces breakthrough vaccine manufacturing platform

13 Jan 2019

The automated NevoLine bioproduction system that facilitates safer, faster and closed bioprocessing in a much smaller footprint.

Read more 
BMS and Celgene merge to create premier innovative biopharma company

BMS and Celgene merge to create premier innovative biopharma company

3 Jan 2019

Significantly expands Phase III assets with six expected near-term product launches, representing greater than $15 billion in revenue potential.

Read more 
An increased risk of a hard or ‘no deal Brexit?

An increased risk of a hard or ‘no deal Brexit?

24 Dec 2018

A ‘no deal’ Brexit will change and burden how all industries that move materials and goods across borders, including the pharmaceutical and medical device sectors, do business.

Read more 
One month on: medical cannabis is still taboo despite change in law

One month on: medical cannabis is still taboo despite change in law

11 Dec 2018

Restrictive guidelines have led many to buy CBD products online, leading to a boom in production with many products going to market without sufficient quality control.

Read more 
EU FMD - time is running out!

EU FMD - time is running out!

13 Nov 2018

Companies that have left it too late to implement their own solution will have to rely on support from providers, whose resources are already in high demand as the deadline approaches.

Read more 
Proprietary nasal delivery formulation of diazepam reaches NDA

Proprietary nasal delivery formulation of diazepam reaches NDA

7 Nov 2018

The absolute bioavailability of the Valtoco intranasal formulation was 96% of intravenous diazepam in a Phase I cross-over trial.

Read more 
DSCSA one-month countdown!

DSCSA one-month countdown!

30 Oct 2018

With only a month to go, it really is too late to start trying to develop an in-house solution.

Read more